Broadwood Partners, L.p.

Insight Molecular Diagnostics Inc. · 10% Owner

Broadwood Partners, L.p. is listed in public filings as 10 percent owner. This Broadwood Partners, L.p. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Insight Molecular Diagnostics Inc. (IMDX), and STAAR Surgical Company (STAA). Investors use Broadwood Partners, L.p.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Insight Molecular Diagnostics Inc.IMDX$913k250.9k sharesBuyApr 27, 2026$3.64--
Insight Molecular Diagnostics Inc.IMDXDisclosure amount unavailableBuyApr 27, 2026----